NL-OMON46628撤回2 期
MRI-guided single dose preoperative radiotherapy in low-risk breast cancer - ABLATIVE-2
niversitair Medisch Centrum Utrecht0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Female, ><= 50years, breast cancer, ER positive tumor, Her2 negative tumor, tumor maximum 3cm in diameter, BR grade 1 or 2
排除标准
- •Indication for chemotherapy, lobular carcinoma, previous breast cancer, lymph node or distant metastasis, BRCA1, BRCA2 or CHEK2 gene mutation
研究者
相似试验
已完成
不适用
MRI for radiotherapy treatment planning of stage III NSCLC: an MRI optimization study in healthy volunteers and patients1003866610029107lung cancernon-small cell lung cancerNL-OMON44655niversitair Medisch Centrum Utrecht40
尚未招募
不适用
Ontwikkeling van een MRI-scanningsprotocol voor het afbeelden van stadium III niet-kleincellig longkanker.1. Healthy volunteers 2. Patients with stage III NSCLC MRINL-OMON27984niversity Medical Center Utrecht30
撤回
2 期
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast CancerBreast CancerNCT03863301UMC Utrecht
已完成
不适用
Developing methods to allow adaptive radiotherapy for gynaecological cancers with Magnetic Resonance Imaging (MRI)Gynaecological CancerCancer - Cervical (cervix)Cancer - Womb (Uterine or endometrial cancer)Cancer - Other cancer typesACTRN12615000862549Dr Karen Lim32
尚未招募
2 期
Preoperative short-term radiotherapy for primary resectable rectal cancer: Accelerated once daily (5x5Gy) versus accelerated hyperfractionated twice daily (12x2,5Gy b.i.d.) (ONCE-TWICE trial) A phase II single-blinded multi-institutional randomised studybowel cancerrectal cancer10017991NL-OMON29980niversitair Medisch Centrum Groningen210